Curcuma caesia (Curcuma caesia): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Curcuma caesia work for epilepsy?

Curcuma caesia, or black turmeric, exerts its neurological effects primarily through volatile oils such as ar-turmerone and camphor. These compounds are believed to modulate neurotransmitter activity, potentially interacting with GABAergic pathways to reduce neuronal excitability. While these mechanisms are promising, current evidence is limited to preclinical studies (Evidence Level C), and more human trials are needed to fully understand its anticonvulsant action.

Does Curcuma caesia interact with epilepsy medications?

Yes, Curcuma caesia poses a significant risk of interaction with antiepileptic drugs. Because the herb possesses potential anticonvulsant properties, taking it alongside prescription seizure medications may potentiate effects or interfere with drug metabolism, leading to unpredictable seizure control. Patients taking medication for epilepsy should avoid this herb unless specifically monitored by a healthcare provider.

What is the recommended daily dosage for Curcuma caesia?

The standard adult dosage for Curcuma caesia rhizome powder is typically 1 to 3 grams daily. This amount is based on traditional Ayurvedic use and pharmacopoeia standards rather than robust clinical trials (Evidence Level C). It is generally taken orally with water. Users should start with the lower end of the range to assess tolerance, as higher doses may cause gastrointestinal upset.

Is Curcuma caesia safe to take during pregnancy?

No, Curcuma caesia is considered unsafe during pregnancy. The rhizome contains compounds like camphor and specific turmerones that may stimulate uterine contractions or pose toxicity risks to the developing fetus. Due to these potential emmenagogue effects and a lack of safety data, pregnant and breastfeeding women should strictly avoid supplementation with black turmeric.

What are the traditional uses of Curcuma caesia?

In Ayurvedic tradition, Curcuma caesia is primarily used for managing neurological conditions, epilepsy, and paralysis due to its neuroprotective reputation. It is also employed as a remedy for respiratory issues like asthma, rheumatic pain, and various skin diseases. While these uses are well-documented in traditional texts, scientific validation remains limited (Evidence Level C).

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Curcuma caesia, also known as black turmeric, is a medicinal herb from the Zingiberaceae family indigenous to India and Southeast Asia, recognized for its antioxidant, anti-inflammatory, and anticancer properties [PMID:37200789, 36704214, 41317210].

Background

Curcuma caesia (black turmeric) is a perennial herb characterized by bluish-black rhizomes and a camphoraceous aroma [PMID:41253921, 36704214]. It is an endangered species often collected from the wild in India and Southeast Asia [PMID:36292691, 37200789].

Traditional uses

In Indian and Ayurvedic medicine, it is traditionally used to treat cancer, bruises, inflammation, asthma, leukoderma, tumours, piles, and bronchitis, and is used as an aphrodisiac [PMID:23527894, 28962377, 17317653]. Tribal communities in North-East India also use it for the treatment of arthritis [PMID:41141599].

Active compounds

The herb contains essential oils including camphor, ar-turmerone, (Z)-β-ocimene, ar-curcumene, 1,8-cineole, β-elemene, borneol, bornyl acetate, tropolone, ledol, β-elemenone, and α-bulnesene [PMID:36704214]. Other identified compounds include sesquiterpenes, monoterpenes, curzerenone, curcuzederone, germacrone, and zerumbone [PMID:41413130, 41253921, 31726856]. Notably, curcumin was not detected in C. caesia extracts [PMID:37592890].

Mechanism of action

C. caesia exhibits antioxidant activity by reducing oxidative stress [PMID:30767224]. It has demonstrated the ability to inhibit cyclooxygenase (COX-1 and COX-2) enzymes [PMID:23359084] and induce cell arrest at the G2/M phase and cellular apoptosis in cancer cells [PMID:28733192]. It also shows smooth muscle relaxant effects in the bronchioles and vasculature [PMID:17317653].

Clinical evidence

Evidence BOral Submucous Fibrosis (OSMF)

Powdered C. caesia mixed with honey showed significantly more symptomatic improvement (reduction in burning sensation, improved cheek flexibility, mouth opening, and tongue protrusion) compared to C. longa [PMID:41148610]

Evidence DCancer (Ehrlich's ascites carcinoma in mice)

Methanol extract of rhizomes demonstrated antitumor activity, reducing tumor volume and weight [PMID:23527894]

Evidence DCervical Cancer (In vitro)

Methanolic extract induced DNA damage and apoptosis in HeLa and SiHa cell lines [PMID:41862889]

Evidence DBreast Cancer (In vitro)

Curcuzederone significantly inhibited the migration of triple-negative breast cancer cell line MDA-MB-231 [PMID:31726856]

Evidence DPeriodontal Infection (In vivo/In vitro)

A mucoadhesive gel encapsulating C. caesia leaf essential oil (with borneol as a major constituent) showed faster recovery of infection [PMID:40671580]

Safety & adverse effects

Elemental analysis of rhizomes indicates that heavy metal levels are within the toxicity limits set by the World Health Organization, suggesting it is safe for medicinal purposes [PMID:38940214].

Evidence summary

The evidence consists primarily of in vitro studies, animal models, and one non-randomized clinical trial. While there is strong laboratory evidence for antioxidant and anticancer activity, clinical data is very limited.

PubMed sources

1.PMID: 30767224 (2019) — Investigation of the utility of Curcuma caesia in the treatment of diabetic neuropathy. · The Journal of pharmacy and pharmacology
2.PMID: 37200789 (2023) — 1H NMR-Based Metabolomics Approach Revealing Metabolite Variation of Black Turmeric (Curcuma caesia) Extracts and Correlation with Its Antioxidant and α-Glucosidase Inhibitory Activities. · Food technology and biotechnology
3.PMID: 32862164 (2020) — Effect of temperature and pressure on antimycobacterial activity of Curcuma caesia extract by supercritical fluid extraction method. · International journal of mycobacteriology
4.PMID: 23359084 (2013) — Functional food quality of Curcuma caesia, Curcuma zedoaria and Curcuma aeruginosa endemic to Northeastern India. · Plant foods for human nutrition (Dordrecht, Netherlands)
5.PMID: 41909252 (2026)

Curcuma caesia

Sources & Citations

Calculate a safe dose of Curcuma caesia